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Abstract  
 
Background: The risk of type 2 diabetes is increasing in teenage girls, and is associated with their 
greater insulin resistance (IR).  
Hypothesis: We hypothesised that the adverse metabolic profile of girls (compared with boys) 
would persist from childhood through adolescence.  
Patients and Methods:  Community-based longitudinal cohort of 292 children (147 boys) studied 
annually from 9-16y. Measures: IR (homeostasis-model-assessment-2), HDL-cholesterol (HDL-
C), triglycerides, % body-fat (dual-energy x-ray absorptiometry), pubertal stage (age at peak 
height velocity), physical activity (accelerometry).  Multi-level modelling established the age-
related trends in IR and lipids and the influence of covariates. 
Results:  Each year from 9-15y, girls had 21-63% higher IR than boys (girls mean IR 0.73-1.33, 
boys 0.51-0.89, p<0.005). At 16y the gender difference was not significant (girls IR 0.60, boys 
0.56, p=0.45). Girls had lower HDL-C from 9-12y, higher triglycerides 9-14y, greater adiposity 
throughout, and earlier puberty, but boys were more active than girls (all p<0.05).  
After adjustment for %-fat, puberty and activity, the gender difference in IR between girls and boys 
aged 9-15y became non-significant: (IR girls 0.66-1.01, boys 0.65-1.04, p>0.07). However, after 
adjustment at 16y, girls’ IR was 25% lower than boys’ (girls 0.44, boys 0.63, p=0.001), and they 
had 22% higher HDL-C (p<0.001) and 20% lower triglycerides (p=0.003). 
Conclusions: The higher IR of pre- and early pubertal girls diminishes during late puberty, and 
boys begin to exhibit greater metabolic risk. Despite being leaner and more active, boys at 16y 
have higher IR than girls, suggesting future higher risk for diabetes, thus we reject our hypothesis. 
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Abbreviations 
APHV  Age at Peak Height Velocity 
BMI  Body Mass Index 
CV  Coefficient of Variance 
DEXA  Dual Energy X-ray Absorptiometry 
HDL-C  High Density Lipoprotein Cholesterol 
HOMA-IR Homeostasis Model Assessment of Insulin Resistance 
IR  Insulin Resistance 
MVPA  Moderate to Vigorous Physical Activity 
SDS  Standard Deviation Score 
T2D  Type 2 Diabetes 
  
 
 
Introduction 
Type 2 diabetes (T2D) is presenting at increasingly younger ages, and the diagnosis is often 
made in the teenage years (1). T2D in children has become a serious public health concern, 
and in some high-risk populations it is now more common than type 1 diabetes (2). The risk of 
T2D in this age group is strongly associated with obesity (2); 92% of children with T2D have 
been reported as overweight or obese (3). 
 According to a large recent study from North America, T2D prevalence was 0.58 per 1000 in 
girls and 0.35 per 1000 in boys (4), and other studies have reported a female excess of T2D 
among children and adolescents (3, 5, 6). These observations contrast with findings in adults, 
where men are reported to be at higher risk than women (7, 8). The explanation for the gender 
difference in the prevalence of T2D between adults and adolescents is uncertain, however, it 
has been proposed that endocrine changes leading to pubertal insulin resistance (IR) may be 
among the factors influencing the risk of T2D in children (9). There may be a ‘cross-over’ of the 
gender difference in IR between childhood and adulthood, with a decline in IR in post-pubertal 
females relative to males. These changes could reflect age- and gender-dependent changes in 
adiposity. Logue et al (10) reported that men develop T2D at a lower BMI than women, and 
suggested this was because men are more insulin resistant and have more central fat than 
women.  
Cross-sectional studies at birth (11) and throughout the prepubertal years (12, 13) have 
consistently shown higher fasting insulin concentrations in females. These have also been 
observed in longitudinal studies during adolescence (14, 15). The EarlyBird longitudinal study 
has previously reported higher levels of  IR in five-year-old girls compared with boys, even after 
accounting for differences in adiposity and physical activity (16). Moreover, it is well established 
that puberty is associated with a substantial increase in IR (17, 18). Gender differences in IR 
 
 
have been attributed to differences in adiposity, fat distribution, sex hormones and pubertal 
timing (19, 20). The temporal influence of different factors can only be investigated with 
longitudinal studies. EarlyBird is a unique longitudinal study of the same children over a period 
of 12 years. Gender differences from 5-8y have been reported previously(16). The aim of this 
analysis was to investigate gender differences in IR between 9-16y. We hypothesised that the 
adverse metabolic profile of girls (compared with boys) would persist from childhood through 
adolescence.  
  
 
 
Patients and Methods 
Design, setting and participants: EarlyBird is a non-intervention longitudinal cohort study of 347 
children (174 boys, 173 girls) recruited from 53 primary schools in Plymouth, UK. Exclusion 
criteria were diabetes, pathological states likely to affect growth or body composition, moderate 
or severe physical disability, and long term use of oral steroids. Three hundred and seven 
children were recruited at 5y in 2000-01 and 40 more at age 9y in 2004-05 to redress a gender 
imbalance. Most were white Caucasian (n=342) and five children (three girls, two boys,1.5% of 
the cohort) were of mixed race, reflecting the racial mix of the city (98.4% white Caucasian 
according to the 2001 Census) (21). Children were seen annually (mean interval 1.0 year, SD 
0.1). Assent from the child at each visit and written consent from the parent were obtained. 
Ethical approval was granted by the Local Research Ethics Committee in 1999 and updated 
regularly. The study has been reported in detail elsewhere (22). 
 
Main outcome measure: Insulin resistance was measured by Homeostasis Model Assessment-2 
method using the HOMA-IR program, downloaded from the University of Oxford Diabetes Trials 
Unit website (www.dtu.ox.ac.uk)) (23). A venous blood sample was taken at 9am after an 
overnight fast. Serum insulin was measured by Immulite analyser (Diagnostic Products 
Corporation, USA), cross-reactivity with proinsulin <1%, inter-assay coefficient-of-variation (CV) 
9%, detection limit of the assay 2.0 mU/l (14 pmol/l). Glucose was measured using Cobas 
Integra 700 analyser (Roche Diagnostics, UK; inter-assay CV 2%). HOMA-IR has been 
validated against the euglycemic clamp (r=0.91) in healthy youths (24). 
 
Secondary outcome measures: HDL-cholesterol and triglycerides measured using Cobas 
Integra 700 analyser (Roche Diagnostics, UK), inter-assay CV 2%.  
 
 
 
Predictor variables: Gender; age; height measured to nearest 1mm (Leicester Height Measure, 
Child Growth Foundation, London); weight measured to nearest 200g (Tanita Solar 1632W 
electronic scales, West Drayton, Middx; body mass index (BMI) standard-deviation-scores (sds) 
were calculated (25); waist circumference measured by metal tape, Chasmors Ltd, London); 
body fat (% fat) measured annually by dual energy x-ray absorptiometry (DEXA) by Prodigy 
Advance fan beam densitometer (GE Healthcare).   
Pubertal status measured by age at peak height velocity (APHV), determined as the tangential 
velocity at the middle time-point of three consecutive height measurements taken six months 
apart. APHV, an objective measure of puberty, allows comparison of pubertal development 
between genders (26, 27). 
Physical activity was measured by Actigraph accelerometers (Model 7164, Fort Walton Beach, 
FL), having good technical reproducibility (28). Accelerometers were worn around the waist and 
recorded continuously for 7-days each year. The children wore the accelerometer every day 
from getting up until going to bed, removing it only for water-based activities, and keeping a 
diary of any activity undertaken while not wearing the accelerometer. Only recordings capturing 
at least four days of monitoring (each incorporating at least nine hours’ wear time, and including 
at least one weekend day) were included in the analyses. Time spent in moderate-and-vigorous 
intensity physical activities (MVPA; minutes/week) was calculated against the threshold specific 
to three metabolic equivalents of task (METs), deemed by the UK Government to be the lower 
limit of moderate activity (29). 
Children’s MVPA varied little from 9 to 16y (30), and in order to characterise the overall long-
term physical activity level of each child, their MVPA was averaged across all eight time points. 
In doing so, the children were ranked according to their activity levels throughout the whole 
period with 95% reliability, compared with 70% reliability when using one annual measure of PA 
(30). 
 
 
 
Statistical analysis: The distributions of HOMA-IR, triglycerides, % fat and MVPA, were skewed 
in both genders and were log-transformed for analysis and back-transformed for presentation. 
Cross-sectional analyses were performed using IBM SPSS version 22 (IBM Corp., 
Armonk,NY).The gender difference between mean values was expressed as a percentage. 
Differences between individuals were assessed by independent t-tests. Univariate regression 
explored the association between the outcome variable and predictor variables.  
 
Longitudinal data were analysed using linear mixed-effects modelling taking into account all 
available data at each time-point (R software (31) using lmer function in lme4 (32)). The effect of 
covariates on the gender difference in IR over time was examined. Random intercepts were 
included as well as age (categorized to allow for non-linear change in IR over time), gender, % 
fat, APHV and MVPA as fixed effects. Two-way interactions between the covariates, age and 
gender were examined and retained in the model if significant at the 5% level or of particular 
interest. Interpretation of the model coefficients was facilitated by plotting.  
 
  
 
 
Results 
292 children (147 boys) had measures of IR at 9y (84% of the cohort), and these subjects were 
used for this analysis. Descriptive characteristics are shown in Table 1. The girls attained peak 
height velocity 1.64y before boys. Girls had significantly higher % body fat at each age, larger 
waist circumferences from 10y onwards and a significantly higher BMIsds at 14y (p=0.003).  
 
IR rose and fell through puberty in both genders, with boys reaching peak IR at 14y, and girls at 
12y. IR was significantly higher in girls than boys at each age up to 15y, with the biggest gender 
difference at 12y. Girls had 13-18% higher triglycerides than boys from 9-14y (p<0.032) but the 
difference was no longer significant at 15 and 16y. Boys had 3-7% higher HDL-cholesterol than 
girls from 9-12y (p<0.02), whereas by 15y girls had 7% higher HDL-cholesterol (p=0.02), and by 
16y girls were 9% higher (p<0.001).  
 
Univariate Regression (Supplementary Table 1) 
Predictor variables were added separately at each age to assess their contribution to IR. The 
variable having the greatest effect on the gender difference in IR was % fat. After adjusting for 
fat there was no significant gender difference in IR at ages 9-11, 14 and 15y.  At 12 and 13y, 
girls were still more insulin resistant than boys after accounting for fat (p<0.001 and 0.018 
respectively), and at 16y, girls were 40% less insulin resistant than boys (p<0.001). Waist 
circumference, BMI, APHV and MVPA each had more modest effects in attenuating the gender 
difference in IR. When these variables were included in the models, girls remained more insulin 
resistant than boys throughout.   
 
Adjusting for %fat, APHV and MVPA increased the gender difference in HDL-C levels at 16y, 
with %fat having the greatest effect (girls 25% higher than boys; p<0.001)). The only predictor 
 
 
variable which influenced the gender difference in triglycerides at 16y was %fat, adjusting for 
which led to girls having 20% lower levels than boys (p<0.001). 
Fasting glucose levels were significantly higher in the boys than girls at 10y and 13-16y. The 
gender difference in glucose was explained by APHV at 14 and 15y, but adjusting for adiposity 
and MVPA made little difference.  
 
Longitudinal modelling 
The measure of adiposity explaining the greatest proportion of the gender difference in IR was 
total % fat, therefore this was included as a covariate in the longitudinal models along with 
objective measures of APHV and MVPA, since these are also known to influence IR.  
Figure 1 shows mean (95% CI) IR in boys and girls from 9-16y. Figure 1a shows the unadjusted 
IR (Model estimates are given in Supplementary Table 2). Figure 1b shows IR adjusted for 
APHV alone, Figure 1c shows IR adjusted for APHV and MVPA, Figure 1d shows IR adjusted 
for APHV, MVPA and % fat. The inclusion of all three covariates in the model affected the 
gender difference in IR such that there was a cross-over between 13y and 14y so that by 16y, 
IR in girls was ~25% lower than in boys.  
Figure 2 shows the mean (95% CI) HDL-C and triglycerides in boys and girls from 9-16y. Figure 
2a (raw data) shows that HDL-Cholesterol fell from 9-16y, with the fall more marked in boys. 
After adjustment (Figure 2b), HDL-C became significantly higher in the girls from 12y onwards 
such that by 16y, HDL-C was ~22% higher in girls than boys (Supplementary Table 3). 
Triglycerides increased in both genders, girls having 13-18% higher levels than boys from 9-14y 
(raw data, Figure 2c). However, after adjustment for % fat, APHV and MVPA, there was no 
gender difference in triglycerides until 16y when the girls had ~20% lower levels than boys 
(Figure 2d; Supplementary Table 4).  
 
 
Discussion 
The principal finding of this study was that IR is significantly higher in adolescent girls than boys, 
and this gender difference narrows and reverses by age 16y, at which age boys become more 
insulin resistant than girls. After adjusting for factors known to influence IR, the gender 
difference in IR between 9-15y was largely attributable to differences in adiposity. Furthermore, 
these findings were largely mirrored by changes in levels of triglycerides and HDL-cholesterol 
levels, which support the likely biological significance of the temporal changes in IR.  
Fasting glucose levels were slightly higher in boys, and this gender difference was attenuated to 
some extent by pubertal stage, and not by adiposity or activity. Relatively higher glucose in boys 
at 16y (by 4%) could have contributed to their higher adjusted IR at 16y, but is unlikely to have 
affected their lipids.  
This analysis extends the findings of Moran et al (14), who studied 350 children aged 11-15y at 
baseline, with 55% cohort retention at 18-19y. In that study IR was higher in girls at 11y, and 
higher in boys at 19y. However, the authors did not find any association between pubertal 
development and IR. Our longitudinal dataset with eight measurements at annual time points, 
93% cohort retention for measures of IR and the small age range of the participants has allowed 
us to identify more precisely the age at which this gender reversal in IR occurs. The use of 
linear mixed-effects models allowed incorporation of all covariates and repeated measures 
simultaneously.   
Moran et al (14) did not examine the influence on IR of age-dependent changes in adiposity. 
Changes in IR occur against a background of body fat levels that are declining in boys and 
increasing in girls. These changes reflect increasing lean body mass and falling body fat as 
boys develop adult male body composition. It appears contradictory that IR falls in girls while 
they continue to gain fat mass. Despite these different patterns, the association between IR and 
 
 
percentage fat remained stronger in girls.  This may be of pathophysiological significance, with 
relevance to the excess risk of T2D in adolescent females.  
The raw data results for triglycerides and HDL-cholesterol support the observations of Dai et al 
(33) who studied three cohorts of children measured three times in one year. For both 
measures, girls’ triglycerides were higher and HDL-C lower between 8-11y, but had reversed by 
14y. Our fully-adjusted trends over eight annual time-points are able to pinpoint the ages at 
which this cross-over occurs. There is clear divergence of HDL-cholesterol from 12y onwards 
and of triglycerides from 15y onwards.  The HDL-cholesterol data are in line with the normative 
data collected by the Caliper Study (34), showing slightly higher levels in girls from 13-19y, and 
no gender difference in triglyceride levels.  
The gender differences observed in metabolic variables could be explained by changes in fat 
distribution, with boys accumulating more central adiposity, known to be associated with 
increased IR and diabetes risk, and girls accumulating more subcutaneous and/or gluteal 
adiposity. However, waist circumference-sds increased significantly in the girls from 9-16 years 
but did not change in the boys, suggesting that the girls were accumulating excess abdominal 
fat, while boys were growing at the expected rate. Despite this potential masking effect of 
excess weight gain in girls, we report a cross-over in the gender difference in IR and lipids. 
Therefore, we are unable to explain the observed gender differences in IR and lipids by 
changes in body composition. Further studies using direct measures of visceral adiposity could 
clarify this issue. 
Another possibility is that peri-pubertal changes in IR are influenced by changing sex-steroid 
concentrations. The post-pubertal decline in IR in girls might be related to rising estrogen 
concentrations; estrogen has several insulin sensitising effects (35). Alternatively, rising 
androgen levels in both genders could affect IR. Testosterone has been shown to decrease 
 
 
insulin sensitivity in both men and women (36). However, levels of sex hormone-binding 
globulin, which are strongly influenced by adiposity and IR in childhood (37), modulate the 
bioavailability of estradiol and testosterone so that increasing adiposity augments free 
concentrations of sex steroids.  Therefore, while sex steroids may influence IR, there is a 
complex and probably bidirectional interrelationship. 
Growth hormone and the growth axis are also important determinants of insulin resistance 
during puberty. The association plays an important physiological role, since the acceleration of 
growth during puberty is achieved in an energy-efficient manner mediated, at least in part, 
through hyperinsulinaemia/insulin resistance (38, 39). The different reproductive destinies of 
each sex place different biological imperatives – with different tempos – on vertical growth and 
the acquisition of fat. 
 
Physical activity is a potential factor that could influence metabolic health in adolescence, and 
may be highly relevant to diabetes and cardiovascular disease prevention strategies in young 
people. Physical activity declines during adolescence (40), and while there was considerable 
inter-individual variation in activity levels at each time point, intra-individual activity remained 
remarkably stable. Ranking the participants according to their eight-year activity levels allowed 
maximum precision, yet the overall contribution of activity to the gender difference in IR and 
lipids was modest.  
We have previously shown that physical activity attenuates the mid-adolescent peak in IR and 
that this effect disappears by 16 years, independent of adiposity and pubertal stage (30). In our 
final model, however, physical activity explained only a small proportion of the gender difference 
in IR. Whether or not a modest increase in physical activity in high risk teenagers reduces their 
risk of T2D remains uncertain.    
 
 
These findings may have practical relevance for early interventions designed to prevent or delay 
the onset of T2D in young people. It can be suggested that the excess risk of T2D in girls may 
be explained by their greater IR, although it is unclear how this is associated with beta cell 
failure. Weight gain between 9-16y, a key influence on IR, is a potential target for intervention. 
Whether or not IR and other characteristics at puberty can predict subsequent hyperglycaemia 
will require longer term follow-up of the cohort.  
This study has strengths and limitations. EarlyBird is a well-established longitudinal cohort study 
with high retention and criterion measures of IR, fatness and activity. The narrow age range and 
multiple repeated measures allow for within- and between-subject comparisons. Longitudinal 
modelling uses all the available data while accommodating missing data points, and our 
methods allowed for retention of subjects in analyses despite some missing data points. 
Inevitably some data is missing over an eight year study, particularly measures of MVPA at later 
ages, and reliability was maximised by calculating a mean value over eight years. Although 
pubertal stage was not directly assessed, APHV is a well-established objective surrogate for 
direct assessment of pubertal stage. It was unfeasible to take more than one fasting measure 
from the children each year, thus insulin was measured from a single sample rather than the 
mean of three. HOMA is a surrogate measure of IR, but, correlating strongly with results from 
clamp studies, it is the most appropriate measure to use in young children. Accelerometry is a 
robust measure of physical activity, although limitations include the potential to miss upper body 
movement and the fact that they must be removed for water based activities. Activity diaries 
reduced some of these limitations. The EarlyBird cohort is mainly Caucasian, and results may 
not be generalizable to populations with different ethnic composition. The current analysis 
terminates at 16y when the metabolic effects of puberty may persist, especially in boys. Follow-
up to adulthood will confirm whether IR remains higher in post-pubertal males compared with 
 
 
females, before and after adjustment for adiposity, and whether IR is associated with increased 
long term risk for the development of T2D.  
We conclude that the higher insulin resistance of pre- and early pubertal girls appears to be 
largely explained by their greater fat mass, with more modest effects of physical activity and the 
timing of puberty. Around the age of 16 years a ‘cross-over’ point is reached when, despite their 
lower fat mass and higher activity levels,  boys become more insulin resistant than girls, and 
have higher triglycerides and lower HDL-cholesterol levels. The changing risk factors for boys 
and girls will inform diabetes prevention strategies in children.  
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Table 1: Cohort Characteristics 
    Boys   Girls   B vs G 
    n mean SD n mean SD p 
Age at 9y visit (years) 147 8.87 0.29 145 8.83 0.32 0.495 
IMD at 9y   146 24.59 13.74 145 23.39 14.85 0.475 
Age at Peak Height 
Velocity (years) 122 13.27 0.87 127 11.63 1.17 <0.001 
BMI (sds) 9y 147 0.36 1.15 145 0.59 1.09 0.075 
  10y 144 0.43 1.13 141 0.63 1.17 0.135 
  11y 144 0.32 1.20 140 0.57 1.21 0.078 
  12y 144 0.42 1.23 138 0.66 1.20 0.087 
  13y 137 0.46 1.20 127 0.74 1.23 0.059 
  14y 134 0.37 1.17 128 0.80 1.17 0.003 
  15y 121 0.40 1.16 114 0.65 1.09 0.097 
  16y 135 0.41 0.25 128 0.75 1.13 0.019 
Waist 
Circumference 
(sds) 
9y 146 0.44 1.11 143 0.63 1.23 0.173 
10y 144 0.55 1.06 140 0.84 1.25 0.039 
11y 142 0.54 1.07 134 0.96 1.28 0.003 
  12y 139 0.53 1.05 128 1.00 1.32 0.001 
  13y 136 0.54 1.04 127 1.08 1.33 <0.001 
  14y 134 0.48 0.99 128 1.15 1.30 <0.001 
  15y 133 0.46 0.96 127 1.07 1.32 <0.001 
  16y 135 0.48 1.08 128 1.07 1.36 <0.001 
HDL  
Cholesterol 
(mg/dL) (a) 
9y 147 72.70 15.08 145 68.06 14.69 0.007 
10y 143 71.93 15.85 142 67.67 14.69 0.019 
11y 141 68.45 15.47 141 63.42 13.92 0.004 
 12y 139 65.35 14.69 133 60.71 13.53 0.006 
 13y 139 59.17 14.31 133 57.23 13.15 0.339 
 14y 134 55.68 13.15 131 56.07 11.60 0.651 
 15y 134 52.20 11.21 133 55.68 11.60 0.018 
  16y 139 50.27 11.21 135 54.91 11.21 <0.001 
    n median IQR n median IQR p 
Insulin 
Resistance 
(unit) 
9y 147 0.54 0.33-0.81 145 0.76 0.53-1.03 <0.001 
10y 138 0.78 0.53-1.04 142 0.97 0.69-1.33 0.005 
11y 141 0.72 0.46-1.10 141 0.98 0.69-1.52 <0.001 
  12y 139 0.90 0.58-1.23 132 1.36 0.92-1.96 <0.001 
  13y 138 0.89 0.63-1.34 133 1.38 0.92-1.80 <0.001 
  14y 134 0.93 0.57-1.37 131 1.31 0.88-1.66 <0.001 
  15y 135 0.77 0.51-1.23 133 1.09 0.69-1.56 0.001 
  16y 138 0.62 0.23-1.04 133 0.67 0.23-1.09 0.446 
 
 
Table 1: Cohort Characteristics (continued) 
    Boys Girls B vs G 
    n median SD n median SD p 
Triglycerides 
(mg/dL) (b) 
9y 147 46.06 36.3-59.3 145 55.80 36.3-59.3 0.001 
10y 143 49.60 38.1-66.4 142 56.68 38.1-66.4 0.006 
  11y 141 51.37 40.7-68.2 141 62.88 40.7-68.2 0.001 
  12y 139 54.03 39.9-76.2 133 64.66 39.9-76.2 0.005 
  13y 139 57.57 42.5-83.3 133 66.43 42.5-83.3 0.01 
  14y 134 62.00 44.3-79.7 131 70.86 44.3-79.7 0.032 
  15y 135 53.14 44.3-70.9 133 62.00 44.3-70.9 0.118 
  16y 139 62.00 44.3-79.7 135 62.00 44.3-79.7 0.939 
DEXA fat (%) 9y 141 16 11-23 143 24 19-32 <0.001 
  10y 143 19 12-27 143 27 21-34 <0.001 
  11y 136 20 13-29 128 28 22-36 <0.001 
  12y 138 22 15-29 128 28 22-36 <0.001 
  13y 138 20 14-30 132 29 23-36 <0.001 
  14y 137 18 13-26 128 31 27-38 <0.001 
  15y 117 16 12-23 110 33 28-38 <0.001 
  16y 132 16 11-26 126 34 29-38 <0.001 
MVPA 
(minutes  
per week) 
9y 137 413 293-526 135 282 215-362 <0.001 
10y 132 353 243-469 133 261 193-340 <0.001 
11y 130 341 273-469 126 228 165-304 <0.001 
  12y 121 380 260-506 123 237 168-306 <0.001 
  13y 123 380 248-542 127 248 167-306 <0.001 
  14y 128 330 222-499 115 205 151-313 <0.001 
  15y 107 343 207-463 99 207 131-268 <0.001 
  16y 99 314 178-436 106 194 117-285 <0.001 
(a) To convert HDL-cholesterol from mg/dL to mmol/l divide by 38.67 
(b) To convert triglycerides from mg/dL to mmol/l divide by 88.57
 
 
Figure Legends 
Figure 1: Insulin resistance (mean, 95% CI) in children from 9y to 16y according to gender 
(a) Unadjusted 
(b) Adjusted for APHV  
(c) Adjusted for APHV and MVPA) 
(d) Adjusted for APHV, MVPA and % fat 
 
Figure 2: Lipid levels (mean, 95% CI) in children from 9y to 16y according to gender. HDL-cholesterol unadjusted 
(2a), adjusted for % fat, APHV and MVPA (2b); Triglycerides unadjusted (2c), adjusted for % fat, APHV and 
MVPA (2d).  
 
 
Supplementary Table 1: Gender differences in IR at each age. Results from cross-sectional univariate 
regression analyses 
Supplementary Table 2: Coefficients from mixed effects model - the effects of age, gender, APHV, adiposity (% 
fat), and physical activity (average MVPA between 9y-16y) on insulin resistance (log transformed) over time. 
Supplementary Table 3: Coefficients from mixed effects model - the effects of age, gender, APHV, adiposity (% 
fat), and physical activity (average MVPA between 9y-16y) on HDL cholesterol over time. 
Supplementary Table 4: Coefficients from mixed effects model - the effects of age, gender, APHV, adiposity (% 
fat), and physical activity (average MVPA between 9y-16y) on triglycerides over time. 
 
